Skip to main content
. Author manuscript; available in PMC: 2009 Nov 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2008 Nov;14(11):1209–1216. doi: 10.1016/j.bbmt.2008.08.004

Table 2.

Univariate Association of Prognostic Factors and Transplantation Outcomes

Grade 3 or 4 Toxicity by day 100
Duration of Transplant Hospital Stay aGVHD Non-Relapse Mortality Overall Survival
Infection Hepatic
Factor
HR P HR P HR P HR P HR P HR P
Age ≥ 50 years 0.84 0.52 1.1 0.81 1.3 0.19 0.98 0.95 2.0 0.06 1.8 0.02
Active Disease 1.2 0.53 1.5 0.30 1.9 0.001 0.70 0.33 2.2 0.03 3.1 <0.001
HCT-CI ≥ 3 0.97 0.92 1.0 0.93 1.4 0.11 0.65 0.27 1.4 0.37 2.0 0.004
PS ≥ 1 1.0 0.91 2.0 0.05 1.4 0.10 2.4 0.02 3.6 <0.001 2.5 <0.001
CRP, above median 1.8 0.09 3.1 0.01 2.0 0.005 4.1 0.003 3.1 0.01 2.0 0.02
IL-6, above median 1.5 0.24 1.9 0.14 1.3 0.27 1.3 0.75 1.7 0.22 1.3 0.41

aGVHD- Acute graft-versus-host disease

HCT-CI- Hematopoietic Cell Transplantation-Comorbidity Index

PS- Eastern Cooperative Oncology Group Performance Score

CRP- C-reactive protein

IL-6- Interleukin-6

HR - Hazard ratio